Your own choice but can I advice If your going to vote against 3 - vote Yes for 4 ?
Risk Scenario would be if 3 passes you potentially would want 4 to pass as well..
(If 3 does not pass 4 does not pass irregardless..)
Just Saying...... against will be a minus potential $6.5 million in funding..... that money is going to have to come from somewhere... Start passing around the tray..
Y2All 4Me
- Forums
- ASX - By Stock
- PLS
- 1 year investment
1 year investment, page-74
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.02 |
Change
-0.040(1.31%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.02 | $55.82M | 18.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 424619 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 17344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 642 | 3.260 |
1 | 227 | 3.080 |
1 | 600 | 3.050 |
1 | 8 | 3.040 |
5 | 4408 | 3.030 |
Price($) | Vol. | No. |
---|---|---|
2.870 | 351 | 3 |
2.930 | 14024 | 8 |
2.960 | 10941 | 4 |
2.980 | 189 | 2 |
3.000 | 20112 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online